[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

March 2017 | 620 pages | ID: U486B1319D1EN
Venture Planning Group

US$ 8,820.00 US$ 9,800.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the US cancer diagnostics market during the nextfive years. The report examines trends in the US market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the US cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

US Market Overview
  • Five-year test volume and sales projections.
  • Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
  • Estimated universe of laboratories performing cancer diagnostic testing.
  • Cancer statistics, etiology and recent developments in the US.
Business Opportunities and Strategic Recommendations
  • Specific new product development opportunities with potentially significant market appeal during the next five years.
  • Design criteria for new products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
  • Oncogenes
  • Biochemical Markers
  • Growth Factors
  • Colony Stimulating Factors
  • Hormones
  • Immunohistochemical Stains
  • Lymphokines
Supplier Shares, Sales and Volume Forecasts
  • Sales and market shares of major cancer diagnostic product suppliers by individual test.
  • Five-year test volume and sales forecasts for major tumor markers by market segment, including:
  • Hospitals
  • Commercial/Private Laboratories
  • Physician Offices/Group Practices
  • Cancer Clinics
  • Ambulatory Care Centers
Instrumentation Review
  • Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
Technology Assessment
  • Assessment of latest technologies and their potential applications for cancer diagnostic testing.
  • Review of competing/complementing technologies.
  • Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.
Competitive Strategies

Strategic assessments ofmajor suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

The companies analyzed in the report include:
  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech/Leica
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Thermo Fisher
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zilla
Contains 620 pages and 103 tables
I. INTRODUCTION

II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
  1. BIOCHEMICAL TUMOR MARKERS
  2. ONCOGENES
  3. POLYPEPTIDE GROWTH FACTORS
  4. ECTOPIC HORMONES
  5. COLONY STIMULATING FACTORS
  6. LYMPHOKINES
  7. IMMUNOHISTOCHEMICAL STAINS
  8. EMERGING TUMOR MARKERS
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing

VIII. U.S.A.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
    Volume Forecasts by Test and Market Segment
    Sales Forecasts by Test and Market Segment
    Major Supplier Sales and Market Shares

IX. COMPETITIVE PROFILES

    Abbott
    AdnaGen
    Agilent Technologies
    Applied Gene Technologies
    Arca Biopharma
    Beckman Coulter/Danaher
    Becton Dickinson
    Biomedical Diagnostics
    bioMerieux
    Bio-Rad
    CellSearch
    Cepheid
    Correlogic Systems/Vermillion
    Decode Genetics
    Diadexus
    Diagnocure
    Diasorin
    Eiken Chemical
    Elitech Group
    Epigenomics
    Enterix
    Enzo Biochem
    Exact Sciences
    Fujirebio
    Guided Therapeutics
    Hologic/Gen-Probe
    Kreatech/Leica
    Kyowa Medex
    Mackay Life Sciences
    Myriad Genetics
    OncoLab
    Ortho-Clinical Diagnostics
    Panacea Pharmaceuticals
    Polartechnics
    Polymedco
    PreMD
    Qiagen
    Quest Diagnostics
    Radient Pharmaceuticals
    Roche
    Scienion
    Sequenom
    Siemens Healthcare
    Takara Bio
    Targeted Diagnostics & Therapeutics
    Thermo Fisher
    Tosoh
    Veridex
    Wako Pure Chemicals
    Wallac/PE
    Zila
X. Appendix: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

LIST OF TABLES

Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: U.S., Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates
U.S., Laboratories Performing Cancer Diagnostic Tests by Market Segment
U.S., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
U.S., Physician Office Laboratories Performing Cancer Diagnostic Tests By Practice Size
U.S., Total Cancer Diagnostic Test Volume Forecasts by Market Segment
U.S., All Market Segments Major Cancer Diagnostic Test Volume Forecasts
U.S., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
U.S., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
U.S., Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts
U.S., Cancer Clinics Major Cancer Diagnostic Test Volume Forecasts by Test
U.S., Total Cancer Diagnostic Sales Forecasts by Market Segment
U.S., All Market Segment Major Cancer Diagnostic Sales Forecasts by Test
U.S., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.S., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.S., Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecasts by Test
U.S., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CEA Test Volume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Colon-specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Cytokeratins Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Estrogen Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Interferons Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Interleukins Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Occult Blood Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Total Cancer Diagnostics Sales By Major Supplier
U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales By Major Supplier
U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier


More Publications